- CDC
- Heart Failure
- Cardiovascular Clinical Consult
- Adult Immunization
- Hepatic Disease
- Rare Disorders
- Pediatric Immunization
- Implementing The Topcon Ocular Telehealth Platform
- Weight Management
- Screening
- Monkeypox
- Guidelines
- Men's Health
- Psychiatry
- Allergy
- Nutrition
- Women's Health
- Cardiology
- Substance Use
- Pediatrics
- Kidney Disease
- Genetics
- Complimentary & Alternative Medicine
- Dermatology
- Endocrinology
- Oral Medicine
- Otorhinolaryngologic Diseases
- Pain
- Gastrointestinal Disorders
- Geriatrics
- Infection
- Musculoskeletal Disorders
- Obesity
- Rheumatology
- Technology
- Cancer
- Nephrology
- Anemia
- Neurology
- Pulmonology
Antivirals Recommended for Influenza Treatment & Chemoprophylaxis: Basics, Notes, Cautions
This influenza antiviral brush-up slide show reminds you of key features of the 4 FDA-recommended medications, at-a-glance.
Antiviral medications against influenza viruses are essential in the annual effort to reduce the widespread morbidity and mortality that are common results of the infection.
There are 4 FDA-recommended drugs available as treatment for or prophylaxis against the flu: the neuraminidase inhibitors oral oseltamivir (Tamiflu®), inhaled zanamivir (Relenza®), and intravenous peramivir (Rapivab®), and the cap-dependent endonuclease inhibitor baloxavir marboxil (Xofluza®).
Even if your familiar with all of them, click through this quick slide show based on the Centers for Disease Control and Prevention summary for clinicians on management of influenza.
